Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma)

被引:0
|
作者
Jacobsen, S
Halberg, P
Ullman, S
机构
[1] Copenhagen Univ Hosp Hvidovre, Dept Rheumatol, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Rigshosp, Dept Dermatol, Copenhagen, Denmark
来源
BRITISH JOURNAL OF RHEUMATOLOGY | 1998年 / 37卷 / 07期
关键词
mortality; causes of death; Denmark; systemic sclerosis; scleroderma;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To determine survival, mortality and causes of death in Danish patients with systemic sclerosis (scleroderma), and to analyse how these parameters are influenced by demographic variables and the extent of skin involvement. Methods. A cohort of 344 patients with incident systemic sclerosis (SSc) after 1 January 1960 was retrospectively identified, representing 3716 patient-years of follow-up. The vital status at the end of the study ultimo 1996 was established by reviewing the clinical charts and by contacting the Danish Central Person Register. The causes of death were based on information obtained from the hospital charts and the autopsy reports (80%) and death certificates (20%). The extent of skin sclerosis was described by means of a two-subset model (limited and diffuse involvement) and a three-subset model (digital, extremity and truncal involvement) in all patients. Expected numbers of deaths were calculated by means of age- and sex-specific mortality rates of the general Danish population. Results. Crude mortality rates were 6.5 and 3.9%/yr, respectively, in men and women. The standardized mortality ratio (SMR) was 2.9 (95% CI 2.5-3.4) and was not significantly influenced by sex or age at disease onset. Mortality rates were significantly increased in patients with diffuse skin sclerosis (SMR 4.5, 95% CI 3.5-5.7) and patients under the age of 35 yr (SMR 13, 95% CI 2.7-37). Of the 160 patients who died during the study, 41 deaths (26%) were SSc related, accounting for one-third of the excess mortality. Conclusion. We found a significantly increased mortality in patients with SSc, particularly in the subset of patients with diffuse skin sclerosis and in young patients. The excess mortality was due to an increase in both the SSc-related mortality and the unrelated mortality. However. all other subsets also had a significantly increased risk of death, mainly due to an increased risk of death due to causes unrelated to SSc, cancer among others. The Fact that the unrelated mortality in SSc was found to be 2-fold increased suggests that the excess mortality that was classified as unrelated should more appropriately be termed indirectly SSc related.
引用
收藏
页码:750 / 755
页数:6
相关论文
共 50 条
  • [31] Comorbidity burden on mortality in patients with systemic sclerosis
    Fauthoux, Thomas
    Brisou, Damien
    Lazaro, Estibaliz
    Seneschal, Julien
    Constans, Joel
    Skopinski, Sophie
    Duffau, Pierre
    Blanchard, Elodie
    Contin-Bordes, Cecile
    Barnetche, Thomas
    Truchetet, Marie-Elise
    RMD OPEN, 2024, 10 (04):
  • [32] Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality
    De Almeida Chaves, Sebastien
    Porel, Tiphaine
    Mounie, Mickael
    Alric, Laurent
    Astudillo, Leonardo
    Huart, Antoine
    Lairez, Olivier
    Michaud, Martin
    Prevot, Gregoire
    Ribes, David
    Sailler, Laurent
    Gaches, Francis
    Adoue, Daniel
    Pugnet, Gregory
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [33] Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality
    Sébastien De Almeida Chaves
    Tiphaine Porel
    Mickael Mounié
    Laurent Alric
    Léonardo Astudillo
    Antoine Huart
    Olivier Lairez
    Martin Michaud
    Grégoire Prévot
    David Ribes
    Laurent Sailler
    Francis Gaches
    Daniel Adoue
    Gregory Pugnet
    Arthritis Research & Therapy, 23
  • [34] Causes of death in critically ill multiple sclerosis patients
    Karamyan, A.
    Brandtner, H.
    Grinzinger, S.
    Chroust, V.
    Bacher, C.
    Otto, F.
    Reisp, M.
    Hauer, L.
    Sellner, J.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (04): : 305 - 309
  • [35] Causes of death among 93.637 hip fracture patients– data based on the Danish National Registry of causes of death
    Cecilie Korneliusen Rohold
    Jes Bruun Lauritzen
    Henrik Løvendahl Jørgensen
    European Journal of Trauma and Emergency Surgery, 2022, 48 : 1861 - 1870
  • [36] Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis
    Tennoe, Anders H.
    Murbraech, Klaus
    Andreassen, Johanna C.
    Fretheim, Havard
    Garen, Torhild
    Gude, Einar
    Andreassen, Ame
    Aakhus, Svend
    Molberg, Oyvind
    Hoffmann-Vold, Anna-Maria
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (15) : 1804 - 1813
  • [37] Predictors of inpatient mortality in patients with systemic sclerosis: a case control study
    Sehra, Shiv T.
    Kelly, Andrew
    Baker, Joshua F.
    Derk, Chris T.
    CLINICAL RHEUMATOLOGY, 2016, 35 (06) : 1631 - 1635
  • [38] Predictors of inpatient mortality in patients with systemic sclerosis: a case control study
    Shiv T. Sehra
    Andrew Kelly
    Joshua F. Baker
    Chris T. Derk
    Clinical Rheumatology, 2016, 35 : 1631 - 1635
  • [39] CURRENT THERAPY OF SYSTEMIC-SCLEROSIS (SCLERODERMA)
    MULLERLADNER, U
    BENNING, K
    LANG, B
    CLINICAL INVESTIGATOR, 1993, 71 (04): : 257 - 263
  • [40] Mortality in systemic sclerosis
    Karassa, F. B.
    Ioannidis, J. P. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (05) : S85 - S93